High HTLV-I proviral DNA level associated with abnormal lymphocytes in peripheral blood from asymptomatic carriers. 1992

N Tachibana, and A Okayama, and S Ishihara, and S Shioiri, and K Murai, and K Tsuda, and N Goya, and Y Matsuo, and M Essex, and S Stuver
Second Department of Medicine, Miyazaki Medical College, Japan.

The level of proviral DNA in peripheral blood mononuclear cells from a representative group of asymptomatic HTLV-I carriers in Miyazaki district, an HTLV-I endemic area in Japan, was determined by a single-cycle polymerase chain reaction method (PCR). Of 217 subjects, 26% had a high level of proviral DNA, 43% a medium level, 18% a low level, and 13% an undetectable level. In the high-DNA group, 60% had at least 0.6% abnormal lymphocytes on peripheral blood smears, significantly higher than in those with low DNA levels (19%). This association was present for men of all ages and for women under 55. Men were more than twice as likely to have abnormal lymphocytes as well as high levels of proviral DNA. These differences may reflect different host responses to the virus by sex or by the time or route of infection. This study supports the utility of PCR for molecular screening in epidemiologic studies of the natural history of HTLV-I, and may lead to the identification of those carriers who are at greatest risk of developing HTLV-I-induced malignancy.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011533 Proviruses Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology. Provirus
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

N Tachibana, and A Okayama, and S Ishihara, and S Shioiri, and K Murai, and K Tsuda, and N Goya, and Y Matsuo, and M Essex, and S Stuver
February 1993, Journal of neuroimmunology,
N Tachibana, and A Okayama, and S Ishihara, and S Shioiri, and K Murai, and K Tsuda, and N Goya, and Y Matsuo, and M Essex, and S Stuver
January 1997, Journal of biomedical science,
N Tachibana, and A Okayama, and S Ishihara, and S Shioiri, and K Murai, and K Tsuda, and N Goya, and Y Matsuo, and M Essex, and S Stuver
August 1994, International journal of oncology,
N Tachibana, and A Okayama, and S Ishihara, and S Shioiri, and K Murai, and K Tsuda, and N Goya, and Y Matsuo, and M Essex, and S Stuver
August 1994, Journal of neuroimmunology,
N Tachibana, and A Okayama, and S Ishihara, and S Shioiri, and K Murai, and K Tsuda, and N Goya, and Y Matsuo, and M Essex, and S Stuver
December 1998, Journal of neurovirology,
N Tachibana, and A Okayama, and S Ishihara, and S Shioiri, and K Murai, and K Tsuda, and N Goya, and Y Matsuo, and M Essex, and S Stuver
May 1994, Nihon Kyobu Shikkan Gakkai zasshi,
N Tachibana, and A Okayama, and S Ishihara, and S Shioiri, and K Murai, and K Tsuda, and N Goya, and Y Matsuo, and M Essex, and S Stuver
February 2005, Thorax,
N Tachibana, and A Okayama, and S Ishihara, and S Shioiri, and K Murai, and K Tsuda, and N Goya, and Y Matsuo, and M Essex, and S Stuver
November 1991, The Journal of infectious diseases,
N Tachibana, and A Okayama, and S Ishihara, and S Shioiri, and K Murai, and K Tsuda, and N Goya, and Y Matsuo, and M Essex, and S Stuver
August 2018, Journal of neurovirology,
N Tachibana, and A Okayama, and S Ishihara, and S Shioiri, and K Murai, and K Tsuda, and N Goya, and Y Matsuo, and M Essex, and S Stuver
January 2000, Journal of neuroimmunology,
Copied contents to your clipboard!